December 21, 2021 Lab Top-10 PAI Top-10

Thermo Fisher Scientific Updates TaqMan SARS-CoV-2 Mutation Panel to Enable Direct Identification of Omicron Variant

Thermo Fisher Scientific Updates TaqMan SARS-CoV-2 Mutation Panel to Enable Direct Identification of Omicron Variant CARLSBAD, Calif., Dec. 21, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant. The panel is designed... Read more

December 14, 2021 PAI Top-10

Roche’s Polivy combination reduced the risk of disease worsening or death by 27% in people with previously untreated aggressive form of lymphoma

Polivy plus R-CHP is the first treatment regimen to significantly improve outcomes in previously untreated diffuse large B-cell lymphoma in more than 20 years, potentially transforming treatment for people with this disease Four out of ten people receiving the current standard of care for this type of disease will see their cancer return after initial... Read more

December 13, 2021 Bio/Pharma/CRO PAI Top-10

Interim data from phase III HAVEN 6 study demonstrate favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A

People with moderate or mild haemophilia A have significant unmet clinical needs, as this population may not use preventative treatments due to missed or delayed diagnoses of bleeding episodes and a lack of treatment guidelines1,2 New data indicate that Hemlibra has a favourable safety profile in people with moderate or mild haemophilia A without factor... Read more

December 11, 2021 PAI Top-10

Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab

Results to be presented for the first time show mosunetuzumab induces high and durable complete response rates in people with follicular lymphoma who have received two or more prior therapies1 New efficacy data from Roche’s portfolio of cancer immunotherapies demonstrate potential of bispecific antibodies to expand upon current treatment options across several blood cancers Basel,... Read more

December 8, 2021 Lab Top-10 PAI Top-10

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

Thermo Fisher Scientific Completes Acquisition of PPD, Inc. WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for... Read more

December 8, 2021 Lab Top-10 PAI Top-10 Product Launch

PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance

New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron WALTHAM, Mass.–(BUSINESS WIRE)–Dec. 8, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next... Read more

December 6, 2021 Liq. Handling & Robotics PAI Top-10

3D Printing of Nanoporous Polymers

3D printing offers great flexibility in the creation of precisely engineered objects with highly complex geometries. This is rapidly opening up possibilities in many fields, including aerospace, robotics, construction and medicine. External content Nature Communications: 3D printing of inherently nanoporous polymers via polymerization-induced phase separation 3D printing offers enormous flexibility in fabrication of polymer objects... Read more

December 3, 2021 PAI Top-10

Changes in the Board of Directors

03 December 2021 Basel, 3 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting (AGM) scheduled for 15 March 2022. Mr Paul Bulcke, who has been serving on the Board of... Read more

December 3, 2021 PAI Top-10

Changes in the Board of Directors

Basel, 3 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting (AGM) scheduled for 15 March 2022. Mr Paul Bulcke, who has been serving on the Board of Directors since 2011,... Read more